Dianthus Therapeutics
Dianthus Therapeutics raises $288M Public Offering
Quick Facts
Dianthus Therapeutics: Public Offering Funding Round
Dianthus Therapeutics has successfully raised $288M in Public Offering funding.
Company Overview
Biopharma developing therapies for autoimmune and inflammatory diseases
Funding Details
The Public Offering round was led by Public Markets.
Company Information
- Headquarters: Waltham, MA
- Founded: 2020
- Employees: 120+
- Category: HealthTech
Investment
Dianthus Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public Markets: Verified investor in Public Offering
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
